Everand Logo

Welcome to Everand!

  • STAT

    Sam Isaly leaves OrbiMed months after harassment allegations

    More than four months after promising to resign, Sam Isaly has stepped down from biotech’s most powerful hedge fund in the wake of allegations of rampant sexual harassment.
    by Damian Garde Apr 27, 2018 1 minute

    More than four months after from biotech’s most powerful hedge fund, Sam Isaly has stepped down from in the wake of allegations of rampant sexual harassment.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
    STAT1 min read
    STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
    If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
    Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.